Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers

标题
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
作者
关键词
Breast cancer, BRCA1, and , BRCA2, mutations, RANKL, OPG, Carcinogenesis, Cancer prevention
出版物
EBioMedicine
Volume 2, Issue 10, Pages 1331-1339
出版商
Elsevier BV
发表日期
2015-09-09
DOI
10.1016/j.ebiom.2015.08.037

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now